Product Description: INH14 is a cell permeable inhibitor of IKKα/IKKβ, with IC50s of 8.97 and 3.59 μM, respectively. INH14 inhibits the IKKα/β-dependent TLR inflammatory response. INH14 also inhibits downstream of TAK1/TAB1 and NF-kB pathways. Anti-inflammatory and anti-cancer activity[1].
Applications: Neuroscience-Neuromodulation
Formula: C15H16N2O
References: [1]Drexel M, et al. INH14, a Small-Molecule Urea Derivative, Inhibits the IKKα/β-Dependent TLR Inflammatory Response. Chembiochem. 2019 Mar 1;20(5):710-717.
CAS Number: 200134-22-1
Molecular Weight: 240.30
Compound Purity: 98.0
Research Area: Cancer; Inflammation/Immunology
Solubility: DMSO : ≥ 125 mg/mL
Target: IKK